Brian Alster, head of third-party risk and compliance solutions with Dun & Bradstreet, outlines the steps that procurement organizations should be taking to guard against a growing number of potentially devastating cyber attacks.

Eric Fisch, national sector head for retail and apparel with HSBC Bank USA, offers a preview of how retailers will fare in the coming peak shopping season.

Chris Forrester, chief technology officer with Shyft Network Inc., explains what’s happening with cryptocurrency exchanges, bitcoin and the security of blockchain for non-financial purposes.

Bill Brooks, vice president of transportation with Capgemini North America, Inc., lays out the multiple challenges involved in manufacturing, storing and delivering millions of doses of the vaccine for COVID-19 in the coming months.

Bill DeMartino, managing director for the Americas with Riskmethods, discusses how the coronavirus pandemic is impacting risk-management strategies, and whether companies were ready for the disruption that it has caused.

Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.

Paul Asel, managing partner with NGP Capital, offers a venture capital perspective on the current state and long-term promise of the logistics industry.

Isabelle Glimcher, a fellow at the NYU Stern Center for Business and Human Rights, recommends six steps that government procurement officials should be taking to prevent workers’ rights abuses by suppliers.

Andi Gray, president of Strategy Leaders, describes the plight of small businesses in the pandemic and economic downturn, and emphasizes their importance in a 21^st Century economy.

Suresh Acharya, Professor of Practice at the University of Maryland’s Robert H. Smith School of Business, lays out the challenges of creating an end-to-end supply chain that can produce and distribute millions of doses of a vaccine for COVID-19.